Comparison of Two Topical Formulations Containing Clindamycin and Clotrimazole in Patients With Vaginal Infections

Inclusion Criteria: * Women with symptoms of vaginal discharge and/or odor and a clinical diagnosis of vaginitis of infective origin \[based on symptoms and signs on per speculum examination\] * Age at least 18 years * Capable of giving written informed consent * Agree to no intercourse for 8 days from the day of start of treatment * Agree not to douche or use any intravaginal products during the study period (including tampons, medications and devices) Exclusion Criteria: * Post-menopausal women * Menstruating at diagnosis * Pregnancy * Any antifungal or antibiotic use 14 days prior to enrolment * Use of oral or intravaginal antibiotics within the past 2 weeks * Immunosuppressive drug within 4 months * Presence of vaginal / vulval ulcer * Presence of any other vulval, vaginal or medical condition, including cervical neoplasia/ treatment that might confound treatment response * Inability to keep return appointments * History of hypersensitivity to clotrimazole, clindamycin or lincomycin * History of regional enteritis, ulcerative colitis or antibiotic associated colitis * Significant disease or acute illness that in the Investigators assessment could complicate the evaluation * Intrauterine Device